Status:
UNKNOWN
Smoking Cessation Programme in Workplaces in Hong Kong (Phase Ⅴ)
Lead Sponsor:
The University of Hong Kong
Collaborating Sponsors:
Lok Sin Tong Benevolent Society, Kowloon
Conditions:
Smoking Cessation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Smoking causes cardiovascular and respiratory diseases, cancers and diabetes, and it has been a leading risk factor for death globally. Despite the availability of smoking cessation services locally, ...
Detailed Description
This study will separate into two phases. Phase I is a large scale cross-sectional survey of corporations in Hong Kong to examine the employers' knowledge, attitudes and practices in promoting SC in t...
Eligibility Criteria
Inclusion
- Hong Kong residents aged 18 or above
- Smoke at least 1 cigarette per day or use e-cigarette (EC) or heated tobacco product (HTP) daily
- PSS-4 score ≥ 6, or GAD-2 score≥ 3, or PHQ-2 score≥ 3
- Able to communicate in Cantonese/Mandarin and read Chinese
- Able to use instant messaging tool (e.g. WhatsApp) for communication.
- Stay in Hong Kong during the intervention and follow-up periods (12 months)
Exclusion
- Smokers who are psychologically or physically unable to communicate
- Currently following other smoking cessation program(s)
- Smokers who have severe mental illness
Key Trial Info
Start Date :
April 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04772521
Start Date
April 15 2021
End Date
December 30 2023
Last Update
December 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
School of Nursing, The University of Hong Kong
Hong Kong, Hong Kong